Markus Blocher
Markus Blocher is the majority owner and CEO of Dottikon, a company specializing in the production of chemical substances for the pharmaceutical industry. He is recognized for his pragmatic management style, particularly during the company's significant investment program aimed at expanding production capacity.
Not in the pool (under ¢1).
Recent news mentions
Markus Blocher is the controlling and managing patron of Dottikon ES, a pharmaceutical manufacturer.
Bachem und Dottikon schenken sich im Ringen um Fachkräfte nichts
Switzerland· 2026-05-29
Markus Blocher expressed skepticism about the optimistic timelines for construction projects in the American pharmaceutical industry.
Investitionszusagen steigen auf fast 400 MilliardenSwitzerland· 2025-12-05
Markus Blocher's company has seen a stock increase that somewhat mitigated the family's losses.
«Bilanz»-Liste Reichste 2025: Prominente Manager neu dabeiSwitzerland· 2025-11-28
Markus Blocher resolved issues with the construction of Dottikon ES's new production facility in a decisive manner.
Bachem und Dottikon ES: Die Erntezeit steht anSwitzerland· 2025-10-19
Markus Blocher is the President, CEO, and majority shareholder of Dottikon ES, acknowledging his competitive advantage.
Kunden setzen Schweizer Pharmahersteller wegen Zöllen unter DruckSwitzerland· 2025-09-01
Markus Blocher is the CEO and majority shareholder of Dottikon ES, a pharmaceutical supplier in Switzerland.
Markus Blocher will trotz Zollrisiken von US-Fabrik nichts wissenSwitzerland· 2025-05-28
Markus Blocher, the chairman and majority shareholder, mentioned he cannot yet say if he will make his decision public.
Roche und Novartis sollen mehr Medikamente in den USA produzierenSwitzerland· 2025-04-19
Markus Blocher is mentioned as the owner of Dottikon ES, a company that supplies its customers exclusively from Switzerland.
US-Zölle bedrohen das Geschäftsmodell der Schweizer PharmabrancheSwitzerland· 2025-04-12
Markus Blocher is the majority owner and CEO of Dottikon, noted for his pragmatic leadership.
«Wir haben SGS zu unserer grössten Position ausgebaut»Switzerland· 2025-04-03
